Clinical Research Directory
Browse clinical research sites, groups, and studies.
China Metastatic Liver Cancer Clinical Registry Cohort Database
Sponsor: Anhui Provincial Hospital
Summary
This study is led by the Department of Hepatobiliary Surgery of the First Affiliated Hospital of the University of Science and Technology of China (USTC), in close collaboration with multiple participating centers nationwide. The primary objective is to establish a standardized, large-scale clinical cohort database specifically for metastatic liver cancer. By collecting comprehensive data on patient demographics, primary tumor characteristics, systemic therapies, and local interventions, this registry aims to elucidate the clinical patterns and prognostic factors of secondary liver malignancies. This database will serve as a robust platform for conducting high-quality real-world studies and advancing evidence-based clinical research in the management of metastatic liver cancer.
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2026-06-01
Completion Date
2036-05-31
Last Updated
2026-05-22
Healthy Volunteers
Not specified
Conditions
Interventions
Standard of Care for Metastatic Liver Cancer
In this observational patient registry, no specific interventional procedure is assigned by the investigators. Patients included in the database receive standard clinical management and treatments for metastatic liver cancer according to current clinical guidelines and physician's discretion. These procedures may include hepatectomy, ablation, transarterial chemoembolization (TACE), systemic chemotherapy, targeted therapy, or immunotherapy. This registry aims to evaluate the real-world effectiveness and safety of these standard interventions.
Locations (3)
The First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, China
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Hefei, Anhui, China
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China